SP
ARS Pharmaceuticals, Inc. (SPRY)
NASDAQ·Healthcare·Biotechnology
$7.91
-0.57%
Mkt Cap $823.17M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 9, 2026 | $25.62M | $28.10M | +9.69% | -$0.42 | -$0.42 | +0.00% | — | — |
| Q4 2025 Nov 10, 2025 | $25.58M | $32.50M | +27.04% | -$0.45 | -$0.52 | -15.56% | — | — |
| Q3 2025 Aug 13, 2025 | $27.67M | $15.72M | -43.21% | -$0.41 | -$0.46 | -12.20% | — | — |
| Q2 2025 May 14, 2025 | $14.71M | $7.97M | -45.79% | -$0.35 | -$0.35 | +0.00% | — | — |
| Q1 2025 Mar 20, 2025 | $12.84M | $86.58M | +574.41% | -$0.04 | $0.52 | +1400.00% | — | — |
| Q4 2024 Nov 13, 2024 | $17.08M | $2.07M | -87.89% | -$0.18 | -$0.20 | -11.11% | — | — |
| Q3 2024 Aug 6, 2024 | $1.00M | $500.00K | -50.00% | -$0.12 | -$0.13 | -8.33% | — | — |
| Q2 2024 May 9, 2024 | — | — | — | -$0.11 | -$0.11 | +0.00% | — | — |
| Q1 2024 Mar 21, 2024 | — | $30.00K | — | -$0.14 | -$0.07 | +50.00% | — | — |
| Q4 2023 Nov 9, 2023 | — | — | — | -$0.18 | -$0.16 | +11.11% | — | — |
| Q3 2023 Aug 10, 2023 | — | $10.00K | — | -$0.17 | -$0.18 | -5.88% | — | — |
| Q2 2023 May 15, 2023 | — | $20.00K | — | -$0.17 | -$0.16 | +5.88% | — | — |
| Q1 2023 Mar 23, 2023 | $90.00K | $1.32M | +1362.22% | -$0.13 | $0.77 | +692.31% | — | — |
| Q4 2022 Nov 2, 2022 | — | $189.00K | — | -$0.35 | -$0.50 | -42.86% | — | — |
| Q3 2022 Aug 11, 2022 | — | $464.00K | — | -$0.48 | -$0.55 | -14.58% | — | — |
| Q2 2022 May 12, 2022 | — | $663.00K | — | -$0.54 | -$0.70 | -29.63% | — | — |
| Q1 2022 Mar 31, 2022 | — | $754.00K | — | -$0.70 | -$0.67 | +4.29% | — | — |
| Q4 2021 Nov 10, 2021 | — | $528.00K | — | -$0.67 | -$0.65 | +2.99% | — | — |
| Q3 2021 Aug 12, 2021 | — | $2.11M | — | -$0.53 | -$0.70 | -32.08% | — | — |
| Q2 2021 May 13, 2021 | — | $2.11M | — | -$0.35 | -$0.54 | -54.29% | — | — |